
EBITDA of pharmaceutical company Recordati 2015-2021
The earnings before interests, taxes, depreciation, and amortization (EBITDA) of Italian pharmaceutical company Recordati increased steadily from 2012 to 2021. In 2021, the company reported an EBITDA of 602 million euros. Recordati is an international group headquartered in Milan, whose branches are operational all over the world.